Coccidioidomycosis (Valley Fever) is difficult to diagnosis due to lack of awareness and symptoms imitating many other respiratory infections.
Valley Fever is said to cause nearly 30% of all community acquired pneumonia (CAP) cases, but only about 15,000 cases are reported each year in the US. IMMY’s simple, rapid LFA allows for better care and stewardship for patients.
Key Advantages of the sōna Coccidioides Ab LFA:
● Results in only 30 minutes
● Fewer Send-outs
● High negative Predictive Value
● Reduce Hands-on Time
● Run On All Shifts
Read more: https://www.immy.com/cta